Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease. - Bohm, Matthew; Xu, Ronghui; Zhang, Yiran; Varma, Sashidhar; Fischer, Monika; Kochhar, Gursimran; Boland, Brigid; Singh, Siddharth; Hirten, Robert; Ungaro, Ryan; Shmidt, Eugenia; Lasch, Karen; et al. (Alimentary Pharmacology & Therapeutics, 2020)